Results 11 to 20 of about 12,857 (206)

Hypoaminoacidemia and Pyroglutamic Aciduria: Potential Biomarkers in Malnutrition‐Related Hyperammonemia [PDF]

open access: yesJIMD Reports
Hyperammonemia is a medical emergency, and the cause must be identified quickly in order to treat appropriately. Malnutrition is a known risk factor for hyperammonemia; however, there are limited reliable lab indicators used to identify malnutrition ...
M. M. Crenshaw   +12 more
doaj   +4 more sources

Hyperammonemia in patients receiving valproic acid in the hospital setting: A retrospective review [PDF]

open access: yesMental Health Clinician, 2021
Introduction: Valproic acid (VPA) is widely used for the treatment of epilepsy, migraine, and a variety of psychiatric conditions. The reported incidences of hyperammonemia induced by VPA use is variable.
Tressa McMorris, PharmD, BCPS   +3 more
doaj   +3 more sources

Different types of hyperammonemia in clinical practice [PDF]

open access: yesМедицинский совет, 2018
Hyperammonemia is a metabolic disorder, which is caused as a result of high levels of ammonia present in the blood. Hyperammonemia is related to severe liver diseases, primarily to cirrhosis in 90% of cases.
E. Yu. Plotnikova, A. S. Sukhikh
doaj   +2 more sources

A Case of Hyperammonemia Associated with High Dihydropyrimidine Dehydrogenase Activity [PDF]

open access: yesCase Reports in Oncological Medicine, 2016
Over the past decades, 5-Fluorouracil (5-FU) has been widely used to treat several types of carcinoma, including esophageal squamous cell carcinoma. In addition to its common side effects, including diarrhea, mucositis, neutropenia, and anemia, 5-FU ...
Keiki Nagaharu   +8 more
doaj   +2 more sources

Multiple Asparaginase Infusions Cause Increasingly Severe Acute Hyperammonemia

open access: yesMedical Sciences, 2022
Adverse reactions during and shortly after infusing asparaginase for the treatment of acute lymphoblastic leukemia can increase in severity with later doses, limiting further use and increasing relapse risk.
Randal K Buddington   +2 more
doaj   +2 more sources

Pharmacologic rescue of hyperammonemia-induced toxicity in zebrafish by inhibition of ornithine aminotransferase. [PDF]

open access: yesPLoS ONE, 2018
Hyperammonemia is the common biochemical hallmark of urea cycle disorders, activating neurotoxic pathways. If untreated, affected individuals have a high risk of irreversible brain damage and mortality.
Matthias Zielonka   +5 more
doaj   +2 more sources

Acute pediatric hyperammonemia: current diagnosis and management strategies

open access: yesHepatic Medicine: Evidence and Research, 2018
Nadia Savy,1 David Brossier,2 Catherine Brunel-Guitton,1 Laurence Ducharme-Crevier,1 Geneviève Du Pont-Thibodeau,1 Philippe Jouvet1 1Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada; 2Department of ...
Savy N   +5 more
doaj   +1 more source

Hyperammonemia Post Lung Transplantation: A Review

open access: yesClinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2020
Hyperammonemia is the pathological accumulation of ammonia in the blood, which can occur in many different clinical settings. Most commonly in adults, hyperammonemia occurs secondary to hepatic dysfunction; however, it is also known to be associated with
Ksenia D Guvakova, Robert F Leger
exaly   +2 more sources

FBXL4-related encephalomyopathic mitochondrial DNA depletion syndrome: A rare cause of hyperammonemia

open access: yesMolecular Genetics and Metabolism Reports
Introduction: FBXL4- related encephalomyopathic mitochondrial DNA (mtDNA) depletion syndrome is caused by pathogenic variants in the FBXL4 gene, resulting in mitochondrial dysfunction and multisystem involvement.
Ayça Burcu Kahraman   +4 more
doaj   +2 more sources

Impact of non-hepatic hyperammonemia on mortality in intensive care unit patients: a retrospective cohort study [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2021
Background/Aims The effect of hyperammonemia on the mortality in patients with liver cirrhosis is well documented. However, little is known about the impact of hyperammonemia on mortality among intensive care unit patients without hepatic disease.
Jae Heon Kim   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy